Schmitz Frank, Heit Antje, Dreher Stefan, Eisenächer Katharina, Mages Jörg, Haas Tobias, Krug Anne, Janssen Klaus-Peter, Kirschning Carsten J, Wagner Hermann
Institut fuer Medizinische Mikrobiologie, Immunologie und Hygiene, Technische Universitaet Muenchen, Muenchen, Germany.
Eur J Immunol. 2008 Nov;38(11):2981-92. doi: 10.1002/eji.200838761.
The mammalian target of rapamycin (mTOR) can be viewed as cellular master complex scoring cellular vitality and stress. Whether mTOR controls also innate immune-defenses is currently unknown. Here we demonstrate that TLR activate mTOR via phosphoinositide 3-kinase/Akt. mTOR physically associates with the MyD88 scaffold protein to allow activation of interferon regulatory factor-5 and interferon regulatory factor-7, known as master transcription factors for pro-inflammatory cytokine- and type I IFN-genes. Unexpectedly, inactivation of mTOR did not prevent but increased lethality of endotoxin-mediated shock, which correlated with increased levels of IL-1beta. Mechanistically, mTOR suppresses caspase-1 activation, thus inhibits release of bioactive IL-1beta. We have identified mTOR as indispensable component of PRR signal pathways, which orchestrates the defense program of innate immune cells.
雷帕霉素的哺乳动物靶点(mTOR)可被视为评估细胞活力和应激的细胞主复合体。目前尚不清楚mTOR是否也控制先天性免疫防御。在此,我们证明Toll样受体(TLR)通过磷酸肌醇3激酶/蛋白激酶B(PI3K/Akt)激活mTOR。mTOR与髓样分化因子88(MyD88)支架蛋白发生物理结合,从而激活干扰素调节因子5(IRF-5)和干扰素调节因子7(IRF-7),这两种因子是促炎细胞因子基因和I型干扰素基因的主要转录因子。出乎意料的是,mTOR失活并未预防内毒素介导的休克致死率,反而增加了致死率,这与白细胞介素-1β(IL-1β)水平升高相关。从机制上讲,mTOR抑制半胱天冬酶-1(caspase-1)的激活,从而抑制生物活性IL-1β的释放。我们已确定mTOR是模式识别受体(PRR)信号通路不可或缺的组成部分,该信号通路协调先天性免疫细胞的防御程序。